Skip to main content
. 2022 Jul 8;16(6):695–701. doi: 10.1097/ADM.0000000000001002

TABLE 2.

Characteristics of Interview Participants

Characteristic N = 34
Gender
 Male 16 (47.1%)
 Female 16 (47.1%)
 Other 2 (5.9%)
Age [years] (Mean, SD) 38.7 (8.0)
 <30 3 (8.8%)
 30–39 15 (44.1%)
 40–49 11 (32.4%)
50+ 5 (14.7%)
Ethnicity
 Not Hispanic 28 (82.4%)
 Hispanic 6 (17.6%)
Race
 African American 1 (2.9%)
 American Indian/Alaska Native 0 (0.0%)
 Asian or Pacific Islander 0 (0.0%)
 White 29 (85.3%)
 Multiracial 3 (8.8%)*
 Other 1 (2.9%)
Heroin/Methamphetamine Use in Past 30 days
 Heroin/opioids and methamphetamine/stimulants 28 (82.4%)
 Heroin/opioids (no methamphetamine/stimulants) 3 (8.8%)
 Methamphetamine/stimulants (no heroin/opioids) 3 (8.8%)
Injection Drug Use in Past 30 days
Yes 30 (88.2%)
No 4 (11.8%)
COVID-19 Vaccine Status
 Received vaccine 6 (17.6%)
 Have not received vaccine but plan to 4 (11.8%)
 Have not received vaccine and do not plan to/unsure 24 (70.6%)

*All 3 were American Indian/Alaska Native and another race.